Werewolf Therapeutics (HOWL) Short Interest Ratio & Short Volume $1.93 -0.12 (-5.85%) (As of 11/14/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Werewolf Therapeutics Short Interest DataWerewolf Therapeutics (HOWL) has a short interest of 1.23 million shares, representing 3.76% of the float (the number of shares available for trading by the public). This marks a 58.51% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.0, indicating that it would take 2.0 days of the average trading volume of 376,794 shares to cover all short positions.Current Short Interest1,230,000 sharesPrevious Short Interest776,000 sharesChange Vs. Previous Month+58.51%Dollar Volume Sold Short$3.14 millionShort Interest Ratio2.0 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares44,560,000 sharesFloat Size32,700,000 sharesShort Percent of Float3.76%Today's Trading Volume563,994 sharesAverage Trading Volume376,794 sharesToday's Volume Vs. Average150% Short Selling Werewolf Therapeutics? Sign up to receive the latest short interest report for Werewolf Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHOWL Short Interest Over TimeHOWL Days to Cover Over TimeHOWL Percentage of Float Shorted Over Time Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Werewolf Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20241,230,000 shares $3.14 million +58.5%3.8%2 $2.56 10/15/2024776,000 shares $1.56 million -25.4%2.6%1.5 $2.01 9/30/20241,040,000 shares $2.20 million -7.1%3.4%5.6 $2.12 9/15/20241,120,000 shares $2.62 million +3.7%3.7%3.8 $2.34 8/31/20241,080,000 shares $2.33 million +1.9%3.6%3.5 $2.16 8/15/20241,060,000 shares $2.14 million +3.9%3.5%3.3 $2.02 Get the Latest News and Ratings for HOWL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Werewolf Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/20241,020,000 shares $2.30 million -2.9%3.4%3.2 $2.25 7/15/20241,050,000 shares $3.00 million +55.1%3.5%3.4 $2.86 6/30/2024677,100 shares $1.65 million +38.8%2.3%2.2 $2.44 6/15/2024487,900 shares $1.47 million +4.0%1.6%2.3 $3.01 5/31/2024469,100 shares $2.43 million +26.1%1.6%2.5 $5.17 5/15/2024372,000 shares $1.80 million -10.3%1.3%2 $4.85 4/30/2024414,500 shares $2.59 million +1.1%1.4%2.2 $6.24 4/15/2024410,100 shares $2.25 million -13.1%1.4%1.7 $5.49 3/31/2024472,000 shares $3.06 million +9.3%1.6%2 $6.48 3/15/2024432,000 shares $2.65 million -7.1%1.6%1.7 $6.14 2/29/2024464,800 shares $3.22 million +5.0%1.7%1.7 $6.92 2/15/2024442,600 shares $2.79 million +101.9%2.0%1.7 $6.30 1/31/2024219,200 shares $1.01 million -11.8%1.0%0.8 $4.63 1/15/2024248,600 shares $1.25 million -13.2%1.1%0.3 $5.04 12/31/2023286,500 shares $1.11 million -4.6%N/A0.3 $3.86 12/15/2023300,200 shares $897,598.00 -27.0%1.3%0.3 $2.99 11/30/2023411,400 shares $1.01 million -20.7%1.8%0.5 $2.45 11/15/2023518,500 shares $1.14 million +62.9%2.3%0.6 $2.20 10/31/2023318,400 shares $796,000.00 +562.0%1.4%0.4 $2.50 10/15/202348,100 shares $111,111.00 +14.3%0.2%1.5 $2.31 9/30/202342,100 shares $90,094.00 +10.8%0.2%1.2 $2.14 9/15/202338,000 shares $97,660.00 -5.0%0.2%1 $2.57 8/31/202340,000 shares $109,600.00 -36.1%0.2%1 $2.74 8/15/202362,600 shares $157,126.00 +37.6%0.3%1.4 $2.51 7/31/202345,500 shares $122,395.00 -18.3%0.2%1.1 $2.69 7/15/202355,700 shares $176,012.00 -10.0%0.3%1.4 $3.16 6/30/202361,900 shares $188,795.00 +36.6%0.3%1.6 $3.05 6/15/202345,300 shares $150,849.00 -22.4%0.2%1.1 $3.33 5/31/202358,400 shares $186,296.00 +14.5%0.3%1.4 $3.19 5/15/202351,000 shares $143,310.00 No Change0.2%1 $2.81 10/31/2022153,500 shares $454,360.00 -1.7%1.0%1.6 $2.96 10/15/2022156,200 shares $657,602.00 -15.5%1.0%1.8 $4.21 9/30/2022184,900 shares $833,899.00 +42.7%N/A2.7 $4.51 9/15/2022129,600 shares $789,264.00 -10.3%0.9%0.9 $6.09Election warning coming true… (Ad)If you missed it, my emergency election broadcast is now available - watch it before it's too late.Click here to watch it now. 8/31/2022144,500 shares $731,170.00 -23.9%1.0%1 $5.06 8/15/2022189,800 shares $1.09 million -28.5%1.4%1.3 $5.74 7/31/2022265,300 shares $1.21 million -15.1%2.0%1.8 $4.56 7/15/2022312,500 shares $1.47 million -37.7%2.4%1.8 $4.70 6/30/2022501,600 shares $2.05 million -50.8%3.8%1.3 $4.09 6/15/20221,020,000 shares $4.73 million +2.4%7.8%2.6 $4.64 5/31/2022996,100 shares $3.78 million +7.4%7.6%3 $3.79 5/15/2022927,900 shares $4.40 million +1.7%7.1%2.8 $4.74 4/30/2022912,000 shares $4.06 million +19.3%7.0%2.9 $4.45 4/15/2022764,400 shares $3.51 million +76.5%5.8%2.6 $4.59 3/31/2022433,000 shares $1.91 million +6.6%N/A1.5 $4.40 3/15/2022406,200 shares $1.86 million +19.6%3.1%5.5 $4.59 2/28/2022339,600 shares $2.43 million +15.3%2.6%2.8 $7.16 2/15/2022294,500 shares $2.21 million +3.6%2.3%2.4 $7.49 1/31/2022284,200 shares $2.59 million -60.8%2.2%2.3 $9.11 1/15/2022725,100 shares $6.47 million -7.2%N/A0 $8.92 12/31/2021781,700 shares $9.31 million +23.0%6.0%7.4 $11.91 12/15/2021635,300 shares $8.85 million -2.6%4.9%6.6 $13.93 11/30/2021651,900 shares $9.45 million -1.0%N/A14.4 $14.49 11/15/2021658,300 shares $10.52 million -3.2%5.0%26.3 $15.98 10/29/2021680,100 shares $10.66 million +0.0%4.4%32.4 $15.67 10/15/2021680,000 shares $11.61 million +2.5%4.4%34 $17.07 9/30/2021663,300 shares $11.38 million -2.0%4.3%25.5 $17.16 9/15/2021676,600 shares $11.71 million +3.9%4.6%11.3 $17.30 8/31/2021651,400 shares $11.59 million -0.8%4.4%8.7 $17.80 8/13/2021656,400 shares $9.48 million No Change4.4%7 $14.44 HOWL Short Interest - Frequently Asked Questions What is Werewolf Therapeutics' current short interest? Short interest is the volume of Werewolf Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 1,230,000 shares of HOWL short. 3.76% of Werewolf Therapeutics' shares are currently sold short. Learn More on Werewolf Therapeutics' current short interest. What is a good short interest ratio for Werewolf Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HOWL shares currently have a short interest ratio of 2.0. Learn More on Werewolf Therapeutics's short interest ratio. What is a good short interest percentage for Werewolf Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.76% of Werewolf Therapeutics' floating shares are currently sold short. Is Werewolf Therapeutics' short interest increasing or decreasing? Werewolf Therapeutics saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 1,230,000 shares, an increase of 58.5% from the previous total of 776,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Werewolf Therapeutics' float size? Werewolf Therapeutics currently has issued a total of 44,560,000 shares. Some of Werewolf Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Werewolf Therapeutics currently has a public float of 32,700,000 shares. How does Werewolf Therapeutics' short interest compare to its competitors? 3.76% of Werewolf Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to Werewolf Therapeutics: Adicet Bio, Inc. (4.17%), Rani Therapeutics Holdings, Inc. (7.18%), Shattuck Labs, Inc. (5.31%), Xilio Therapeutics, Inc. (1.86%), Passage Bio, Inc. (3.21%), Curis, Inc. (1.84%), Nektar Therapeutics (2.94%), Canopy Growth Co. (9.77%), Voyager Therapeutics, Inc. (5.41%), Sage Therapeutics, Inc. (11.91%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Werewolf Therapeutics stock? Short selling HOWL is an investing strategy that aims to generate trading profit from Werewolf Therapeutics as its price is falling. HOWL shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Werewolf Therapeutics? A short squeeze for Werewolf Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HOWL, which in turn drives the price of the stock up even further. How often is Werewolf Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HOWL, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies ACET Short Squeeze RANI Short Squeeze STTK Short Squeeze XLO Short Squeeze PASG Short Squeeze CRIS Short Squeeze NKTR Short Squeeze CGC Short Squeeze VYGR Short Squeeze SAGE Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HOWL) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThis small cap’s electric marine powertrain broke the world speed recordThe future of marine propulsion has arrived-powered by a $2 billion powerhouse. In collaboration with McLar...The Tomorrow Investor | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Werewolf Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Werewolf Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.